Mark Plavsic - Jun 14, 2021 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
Chief Technical Officer
Signature
/s/ Cindy R. Tahl, as Attorney-in-Fact
Stock symbol
FATE
Transactions as of
Jun 14, 2021
Transactions value $
$0
Form type
4
Date filed
6/22/2021, 04:03 PM
Next filing
Nov 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Award $0 +38K $0.00 38K Jun 14, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Award $0 +18.5K $0.00 18.5K Jun 14, 2021 Common Stock 18.5K $89.97 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exempt grant of restricted stock units pursuant to the Issuer's Inducement Equity Plan. The units will vest in four annual installments after July 1, 2021, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date.
F2 The option shall vest as to 25% of the underlying shares on June 14, 2022 and thereafter on a monthly basis for 36 additional months, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date.